We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$19.4B
AUM Growth
+$2.92B
(+18%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
9.28%
Top 10 Holdings %
Top 10 Hldgs %
20.62%
Holding
1,394
New
273
Increased
343
Reduced
316
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$694M |
| 2 |
Philip Morris
PM
|
+$316M |
| 3 |
Johnson & Johnson
JNJ
|
+$315M |
| 4 |
Merck
MRK
|
+$303M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$248M |
| 2 |
Micron Technology
MU
|
+$212M |
| 3 |
RAD
Rite Aid Corporation
RAD
|
+$196M |
| 4 |
Comcast
CMCSA
|
+$165M |
| 5 |
GSK
GSK
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.45% |
| 2 | Energy | 18.88% |
| 3 | Healthcare | 17.92% |
| 4 | Financials | 10.19% |
| 5 | Consumer Staples | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCR
351
DELISTED
CR Bard Inc.
BCR
| $7.46M | 0.04% |
+52,142
| New | +$7.45M |
|
|
SYNT
352
DELISTED
Syntel Inc
SYNT
| $7.39M | 0.04% |
171,844
+154,088
| +868% | +$6.34M |
|
353
T-Mobile US
TMUS
$193B
| $7.37M | 0.04% |
+219,283
| New | +$7.09M |
|
354
Royal Bank of Canada
RY
$294B
| $7.36M | 0.04% |
102,707
-101,748
| -50% | -$6.9M |
|
|
CMO
355
DELISTED
Capstead Mortgage Corp.
CMO
| $7.28M | 0.04% |
553,331
+439,515
| +386% | +$5.7M |
|
356
Paychex
PAYX
$42.7B
| $7.17M | 0.04% |
172,485
+164,120
| +1,962% | +$6.75M |
|
|
AFFX
357
DELISTED
Affymetrix Inc
AFFX
| $7.13M | 0.04% |
799,977
-220,665
| -22% | -$1.76M |
|
358
Hawaiian Electric Industries
HE
$2.16B
| $7.12M | 0.04% |
281,300
-17,859
| -6% | -$435K |
|
|
FTR
359
DELISTED
Frontier Communications Corp.
FTR
| $7.12M | 0.04% |
81,250
+23,078
| +40% | +$2M |
|
|
SYA
360
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
| $7.11M | 0.04% |
312,486
-579,589
| -65% | -$12.1M |
|
361
Healthpeak Properties
DOC
$14.5B
| $7.08M | 0.04% |
+187,926
| New | +$7.07M |
|
|
IRF
362
DELISTED
INTL RECTIFIER CORP
IRF
| $7.03M | 0.04% |
251,839
-108,201
| -30% | -$2.9M |
|
363
MGE Energy Inc
MGEE
$3.05B
| $6.88M | 0.04% |
174,230
+146,807
| +535% | +$5.59M |
|
|
EDE
364
DELISTED
Empire District Electric
EDE
| $6.83M | 0.04% |
266,011
+143,476
| +117% | +$3.47M |
|
365
TTEC Holdings
TTEC
$127M
| $6.82M | 0.04% |
235,089
+39,441
| +20% | +$1.02M |
|
366
Gildan
GIL
$10.8B
| $6.75M | 0.03% |
228,572
-1,651,236
| -88% | -$44.1M |
|
367
Ameriprise Financial
AMP
$49.5B
| $6.73M | 0.03% |
56,117
-295,227
| -84% | -$33M |
|
|
UNT
368
DELISTED
UNIT Corporation
UNT
| $6.72M | 0.03% |
97,572
+1,817
| +2% | +$118K |
|
|
SPTN
369
DELISTED
SpartanNash
SPTN
| $6.64M | 0.03% |
316,299
-38,746
| -11% | -$860K |
|
|
MCF
370
DELISTED
Contango Oil & Gas Co.
MCF
| $6.58M | 0.03% |
155,580
+138,513
| +812% | +$6.17M |
|
371
Becton Dickinson
BDX
$48.8B
| $6.52M | 0.03% |
+56,513
| New | +$6.41M |
|
372
SAP
SAP
$230B
| $6.47M | 0.03% |
+83,969
| New | +$6.52M |
|
373
Entegris
ENTG
$21.8B
| $6.42M | 0.03% |
467,448
+274,937
| +143% | +$3.26M |
|
|
WOOF
374
DELISTED
VCA Inc.
WOOF
| $6.41M | 0.03% |
182,628
-461,116
| -72% | -$15M |
|
375
Acadia Healthcare
ACHC
$2.86B
| $6.39M | 0.03% |
140,501
+52,854
| +60% | +$2.32M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Arrowstreet Capital held 1,394 positions worth $19.4B, up 18% from $16.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Arrowstreet Capital deployed $1.81B of net new capital in Q2 2014, opening 273 new positions and adding to 343 existing holdings. Its largest new stake was Johnson & Johnson: 3,117,484 shares worth $326M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $248M trimmed.
- Arrowstreet Capital's largest Q2 2014 buy was Johnson & Johnson: 3,117,484 shares worth $326M.
- Arrowstreet Capital added most to Apple in Q2 2014, an estimated $694M increase.
- Arrowstreet Capital's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $248M.
- Arrowstreet Capital fully exited Comcast in Q2 2014, selling an estimated $165M.
- Arrowstreet Capital's ten largest holdings make up 21% of its $19.4B portfolio in Q2 2014.
- Arrowstreet Capital opened 273 new positions and closed 453 in Q2 2014.
- Arrowstreet Capital's portfolio value rose 18% quarter-over-quarter to $19.4B.
Based on Arrowstreet Capital's 13F filing for Q2 2014, filed 14 Aug 2014.